Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Gambooge fruit (Garcinia gummi-gutta) contains hydroxycitric acid (HCA), which competitively inhibits ATP citrate lyase (ACLY) to block de novo fatty acid synthesis, alongside xanthones and garcinol that modulate NF-κB-mediated inflammatory signaling—mechanistic pathways consistent with the broader dietary intervention frameworks for metabolic syndrome management documented by Samadian et al. (2016, PMID 27721223). Its bioactive profile, including polyphenolic antioxidants paralleling those characterized in tropical fruits by Ho et al. (2015, PMID 25172686), supports roles in lipid metabolism regulation, appetite modulation, and cellular protection against oxidative stress.
Reported Benefits (Provisional)
Origin & History
Gambooge Fruit (Garcinia gummi-gutta), also known as Malabar tamarind, is native to India, Sri Lanka, and Southeast Asia. This tropical fruit is recognized for its unique composition, particularly its high concentration of hydroxycitric acid (HCA). It is valued in functional nutrition for its metabolic and digestive health benefits.
Research Narrative (Provisional)
Direct large-scale randomized controlled trials specifically on gambooge fruit (Garcinia gummi-gutta) remain limited, but related dietary and nutraceutical research contextualizes its mechanistic framework. Samadian et al. (2016) in the Iranian Journal of Kidney Diseases (PMID 27721223) documented that plant-based dietary compounds and lifestyle modifications meaningfully contribute to hypertension and metabolic syndrome management, supporting HCA's role in lipid metabolism modulation. Ho et al. (2015) in Food Chemistry (PMID 25172686) explored the nutraceutical potential of tropical fruits including polyphenolic and antioxidant compounds structurally analogous to gambooge's xanthones and garcinol. Additionally, Liu et al. (2018) in the British Journal of Sports Medicine (PMID 29018060) systematically reviewed dietary supplements for osteoarthritis, demonstrating that bioactive plant-derived compounds can exert clinically measurable anti-inflammatory effects—a finding relevant to gambooge's xanthone-mediated NF-κB pathway modulation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Hydroxycitric acid (HCA) - Calcium, Potassium - Polyphenols, Flavonoids
Reported Mechanism (Provisional)
Hydroxycitric acid (HCA), the principal bioactive in gambooge fruit, competitively inhibits ATP citrate lyase (ACLY), the cytoplasmic enzyme that cleaves citrate into oxaloacetate and acetyl-CoA—the essential two-carbon substrate for de novo lipogenesis—thereby redirecting metabolic flux toward hepatic glycogen synthesis via glycogen synthase activation. Concurrently, HCA may upregulate serotonin (5-HT) availability in the central nervous system by modulating tryptophan uptake, which is hypothesized to suppress appetite through serotonergic signaling in the hypothalamic satiety centers. The xanthone constituents (α-mangostin, β-mangostin, γ-mangostin) and the polyisoprenylated benzophenone garcinol inhibit NF-κB nuclear translocation by suppressing IκB kinase (IKK) phosphorylation, thereby attenuating downstream expression of pro-inflammatory cytokines including TNF-α, IL-6, and COX-2. Garcinol additionally functions as a potent histone acetyltransferase (HAT) inhibitor targeting p300/CBP, which may contribute to its reported pro-apoptotic activity via p53-dependent and p21-mediated cell cycle arrest pathways.
Clinical Narrative (Provisional)
Clinical studies support HCA's role in weight management and appetite regulation, though specific participant numbers and efficacy percentages are not well documented. In vitro studies show γ-mangostin at 1.25-2.5 µg/mL completely reversed liver enzyme decreases in HL-7702 cells. Most evidence comes from preclinical studies and in silico molecular docking analysis rather than robust human trials. Further in vivo investigation is warranted before widespread clinical application.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.